nifedipine has been researched along with Shock in 5 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Shock: A pathological condition manifested by failure to perfuse or oxygenate vital organs.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 77-year-old male with uncontrollable hypertension developed shock, heart block, and multiorgan failure 2 days after clarithromycin was added to his antihypertensive treatment (nifedipine, captopril, doxazosin)." | 7.73 | Clarithromycin-nifedipine interaction as possible cause of vasodilatory shock. ( Cortiñas-Sáez, M; Cuartero-del-Pozo, AB; Gerónimo-Pardo, M; Jiménez-Vizuete, JM; Peyró-García, R, 2005) |
| "Nifedipine toxicity was characterized by vasodilatory hypotension, impaired vascular contractility, and tachycardia with terminal bradycardia." | 5.43 | Pilot Trial of Intravenous Lipid Emulsion Treatment for Severe Nifedipine-Induced Shock. ( Beuhler, MC; Kerns, WP; Murphy, CM; Nicholson, B; Quinn, ME; Shoe, T; Williams, C, 2016) |
| "A 77-year-old male with uncontrollable hypertension developed shock, heart block, and multiorgan failure 2 days after clarithromycin was added to his antihypertensive treatment (nifedipine, captopril, doxazosin)." | 3.73 | Clarithromycin-nifedipine interaction as possible cause of vasodilatory shock. ( Cortiñas-Sáez, M; Cuartero-del-Pozo, AB; Gerónimo-Pardo, M; Jiménez-Vizuete, JM; Peyró-García, R, 2005) |
| "Cardiogenic shock is associated with primary myocardial failure and a low-flow state." | 2.36 | Calcium entry blockers: potential applications in shock. ( Greenfield, LJ; Hess, ML, 1983) |
| "Nifedipine toxicity was characterized by vasodilatory hypotension, impaired vascular contractility, and tachycardia with terminal bradycardia." | 1.43 | Pilot Trial of Intravenous Lipid Emulsion Treatment for Severe Nifedipine-Induced Shock. ( Beuhler, MC; Kerns, WP; Murphy, CM; Nicholson, B; Quinn, ME; Shoe, T; Williams, C, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Soares, C | 1 |
| Gilson, M | 1 |
| Murphy, CM | 1 |
| Williams, C | 1 |
| Quinn, ME | 1 |
| Nicholson, B | 1 |
| Shoe, T | 1 |
| Beuhler, MC | 1 |
| Kerns, WP | 1 |
| Gerónimo-Pardo, M | 1 |
| Cuartero-del-Pozo, AB | 1 |
| Jiménez-Vizuete, JM | 1 |
| Cortiñas-Sáez, M | 1 |
| Peyró-García, R | 1 |
| Hess, ML | 1 |
| Greenfield, LJ | 1 |
| Ramanathan, M | 1 |
| Ahmad, F | 1 |
1 review available for nifedipine and Shock
| Article | Year |
|---|---|
Calcium entry blockers: potential applications in shock.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Coronary Disease; Diltiazem; Dogs | 1983 |
4 other studies available for nifedipine and Shock
| Article | Year |
|---|---|
Nifedipine-Induced Shock in Pregnancy With Aortic Stenosis.
Topics: Aortic Valve Stenosis; Calcium Gluconate; Chest Pain; Electrocardiography; Female; Fetofetal Transfu | 2020 |
Pilot Trial of Intravenous Lipid Emulsion Treatment for Severe Nifedipine-Induced Shock.
Topics: Animals; Blood Glucose; Blood Pressure; Bradycardia; Calcium Channel Blockers; Dihydropyridines; Dis | 2016 |
Clarithromycin-nifedipine interaction as possible cause of vasodilatory shock.
Topics: Aged; Anti-Bacterial Agents; Antihypertensive Agents; Clarithromycin; Drug Synergism; Heart Block; H | 2005 |
Nifedipine-induced hypotensive shock.
Topics: Calcium Channel Blockers; Female; Humans; Middle Aged; Nifedipine; Shock | 1997 |